Diovan
valsartan
- Strength
- 40 mg/1
- Form
- Tablet
- Class
- Angiotensin 2 Receptor Blocker
Novartis Pharmaceuticals Corporation
Listed by AptaPharma Inc.
| Dosage form | Solution |
|---|---|
| Route | Oral |
| Drug class | Angiotensin 2 Receptor Blocker |
| Approval route | NDA — original brand approval |
| NDC code | 76281-155 |
| FDA application | NDA209139 |
| RxNorm concept | 1996254 |
| Package sizes listed | 4 |
| Marketed since | May 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
valsartan
Novartis Pharmaceuticals Corporation
PD-Rx Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.